Research and Markets has announced the addition of the "Global Parkinson's Disease Market Analysis 2016 - Forecast to 2022" report to their offering.
Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
This report provides:
Key Topics Covered:
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Parkinson's Disease Market by Therapy
5.2 Dopamine Replacement Therapies
5.3 MAO-B Inhibitors
5.4 Dopamine Agonists
5.5 Catechol-O-Methyl Transferase COMT Inhibitors
5.6 Adenosine 2A Inhibitor
6 Parkinson's Disease Market by Product
6.2 Nuplazid (pimavanserin)
6.4 Nurelin (Amantadine Hydrochloride Extended-Release)
6.5 APL-130277 (apomorphine hydrochloride)
6.6 P2B001 (pramipexole dihydrochloride + rasagiline mesylate)
6.7 CVT-301 (levodopa)
6.8 Symmetrel (amantadine hydrochloride)
6.9 Dipraglurant Immediate
6.10 ND-0612L (levodopa and carbidopa)
6.11 Exelon (rivastigmine tartrate)
6.12 Nouriast (istradefylline)
7 Geographical Segmentation
8 Vendor Landscaping
9 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/t6tp3g/global
View source version on businesswire.com: http://www.businesswire.com/news/home/20160922006089/en/Business Wire
Last updated on: 22/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.